For all the good it does, a liver protein that senses and gets rid of drugs and pollutants from our body has a downside. For the first time, it has been shown that when it is chronically activated, the protein, called PXR, rejiggers how cholesterol is processed in the liver and increases the risk of developing atherosclerosis. The work has direct clinical consequences to patients under long-term treatment of PXR-activating drugs, including several antibiotic and anti-cancer medications — and your daily latte.
Read the original post:
Scientists reveal a new mechanism that increases atherosclerosis in mice
jouer au poker
Tags: a-liver-protein, antibiotic-and, biomedicine, good-it-does, patients-under
Related posts:
- Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in Apolipoprotein E-knockout mice
- Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer
- High fat diet increases inflammation in the mouse colon
- Elusive protein points to mechanism behind hearing loss
- The development of hepatic fibrosis occurs normally in AMPK deficient mice
Related posts brought to you by Yet Another Related Posts Plugin.
